Notably, the basal expression level of NRF2 protein was higher in androgen-refractory prostate cancer cells (DU-145 and PC-3 cells) when compared with androgen-responsive prostate cancer cells (LNCaP cells). This evidence concerns the gene NFE2L2 and prostate carcinoma.